Zottel, A., Jovčevska, I., Šamec, N., Mlakar, J., Šribar, J., Križaj, I., . . . Komel, R. (2020). Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration. Ther Adv Med Oncol.

Zottel, Alja, Ivana Jovčevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, and Radovan Komel. "Anti-vimentin, Anti-TUFM, Anti-NAP1L1 and Anti-DPYSL2 Nanobodies Display Cytotoxic Effect and Reduce Glioblastoma Cell Migration." Ther Adv Med Oncol 2020.

Zottel, Alja, et al. "Anti-vimentin, Anti-TUFM, Anti-NAP1L1 and Anti-DPYSL2 Nanobodies Display Cytotoxic Effect and Reduce Glioblastoma Cell Migration." Ther Adv Med Oncol 2020.